Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma

Journal of Clinical Oncology

Volumn 24, Issue 21, 2006, Pages 3483-3489

  Cheng, Tsu Yao ^a   Lin, Jaw Town ^a   Chen, Li Tzong ^a   Shun, Chia Tung ^a   Wang, Hsiu Po ^a   Lin, Ming Tsang ^a   Wang, Tsang En ^a   Cheng, Ann Lii ^a   Wu, Ming Shiang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ANTIINFECTIVE AGENT; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INDUCIBLE COSTIMULATOR GENE; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; CASE CONTROL STUDY; GENE FREQUENCY; GENETICS; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; RISK; T LYMPHOCYTE;

ANTI-BACTERIAL AGENTS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; T-LYMPHOCYTES;

EID: 33746833738     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.5434     Document Type: Article

References (42)

1. Fischbach W, Kestel W, Kirchner T, et al: Malignant lymphomas of the upper gastrointestinal tract: Results of a prospective study in 103 patients. Cancer 70:1075-1080, 1992
2. Isaacson PG: Update on MALT lymphomas. Best Pract Res Clin Haematol 18:57-68, 2005
3. Sepulveda AR, Coelho LG: Helicobacter pylori and gastric malignancies. Helicobacter 7:S37-S42, 2002 (suppl 1)
4. Houghton J, Fox JG, Wang TC: Gastric cancer: Laboratory bench to clinic. J Gastroenterol Hepatol 17:495-502, 2002
5. Cavalli F, Isaacson PG, Gascoyne RD, et al: MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 1:241-258, 2001
6. Greiner A, Marx A, Heesemann J, et al: Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 70:572-578, 1994
7. Hussell T, Isaacson PG, Crabtree JE, et al: Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178: 122-127, 1996
8. Guindi M: Role of activated host T cells in the promotion of MALT lymphoma growth. Semin Cancer Biol 10:341-344, 2000
9. Tivol EA, Borriello F, Schweitzer AN, et al: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
10. Waterhouse P, Penninger JM, Timms E, et al: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985-988, 1995
11. Ueda H, Howson JM, Esposito L, et al: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511, 2003
12. Zheng C, Huang D, Liu L, et al: Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma. Br J Haematol 112:216-218, 2001
13. Monne M, Piras G, Palmas A, et al: Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma. Am J Hematol 76:14-18, 2004
14. Piras G, Monne M, Uras A, et al: Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: Association with non-Hodgkin's lymphoma. Br J Haematol 129:784-790, 2005
15. Sharpe AH, Freeman GJ: The B7-CD28 superfamily. Nat Rev Immunol 2:116-126, 2002
16. Kristiansen OP, Larsen ZM, Pociot F: CTLA-4 in autoimmune diseases: A general susceptibility gene to autoimmunity? Genes Immun 1:170-184, 2000
17. Ihara K, Ahmed S, Nakao F, et al: Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 53:447-454, 2001
18. Haimila K, Smedberg T, Mustalahti K, et al: Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun 5:85-92, 2004
19. Rollinson S, Levene AP, Mensah FK, et al: Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 102: 1007-1011, 2003
20. Hellmig S, Vollenberg S, Goebeler-Kolve ME, et al: IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection. Blood 104:2994-2995, 2004
21. Hellmig S, Fischbach W, Goebeler-Kolve ME, et al: Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 46:869-872, 2005
22. Hang J, Zhou W, Zhang H, et al: TLR4 Asp299Gly and Thr399lle polymorphisms are very rare in the Chinese population. J Endotoxin Res 10:238-240, 2004
23. Wu MS, Chen LT, Shun CT, et al: Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 110:695-700, 2004
24. Wu MS, Shun CT, Huang SP, et al: Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma. Haematologica 89:1015-1017, 2004
25. Chen LT, Lin JT, Shyu RY, et al: Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 19:4245-4251, 2001
26. Lee YJ, Huang FY, Lo FS, et al: Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clin Endocrinol (Oxf) 52:153-157, 2000
27. Gough SC, Walker LS, Sansom DM: CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102-115, 2005
28. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, et al: CTLA-4 gene polymorphism is associated with predisposition to celiac disease. Gut 43:187-189, 1998
29. Braun J, Donner H, Siegmund T, et al: CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51: 563-566, 1998
30. Holopainen PM, Partanen JA: Technical note: Linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 167:2457-2458, 2001
31. Marron MP, Raffel LJ, Garchon HJ, et al: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6:1275-1282, 1997
32. Doglioni C, Wotherspoon AC, Moschini A, et al: High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339:834-835, 1992
33. Filipovich AH, Mathur A, Kamat D, et al: Primary immunodeficiencies: Genetic risk factors for lymphoma. Cancer Res 52:S5465-S5467, 1992 (suppl 19)
34. Kouki T, Sawai Y, Gardine C, et al: CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611, 2000
35. Ligers A, Teleshova N, Masterman T, et al: CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145-152, 2001
36. Maurer M, Loserth S, Kolb-Maurer A, et al: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 54:1-8, 2002
37. Anjos S, Nguyen A, Ounissi-Benkalha H, et al: A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277:46478-46486, 2002
38. Xerri L, Devilard E, Hassoun J, et al: In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas. J Pathol 183:182-187, 1997
39. Isaacson PG, Du MQ: MALT lymphoma: From morphology to molecules. Nat Rev Cancer 4:644-653, 2004
40. Amundsen SS, Naluai AT, Ascher H, et al: Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 64:593-599, 2004
41. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000
42. Lohmueller KE, Pearce CL, Pike M, et al: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182, 2003